Literature DB >> 7711879

Abnormalities of endocrine function in patients with clinically "silent" adrenal masses.

B Ambrosi1, S Peverelli, E Passini, T Re, R Ferrario, P Colombo, A Sartorio, G Faglia.   

Abstract

Because, in recent years, patients with incidentally discovered adrenal masses have been encountered increasingly, their endocrine function was investigated in basal conditions and after dynamic tests. Thirty-two patients (23 women and 9 men, aged 28-74 years) were studied. Lesion diameter, as documented by computed tomography and/or nuclear magnetic resonance imaging, ranged between 5 and 65 mm; the tumors were localized on the right in 22 patients, on the left in 5 and bilaterally in 5 cases. In basal conditions, urinary free cortisol (UFC) excretion, plasma adrenocorticotropin (ACTH) and cortisol levels were normal, except for 4 patients who showed high UFC and ACTH levels in the low-normal range. Ovine corticotropin-releasing hormone (CRH, 1 microgram/kg iv) was given to 18 patients, inducing normal ACTH and cortisol responses in 12, blunted responses in 4 and no response in 2 cases. No reduction in ACTH and cortisol levels after suppression tests was observed in 4 of 29 patients after dexamethasone (1 mg overnight) or in 6 of 29 after loperamide. The 4 patients who were unresponsive to both tests did not show any further inhibition after high-dose dexamethasone administration, had low plasma ACTH levels and showed impaired or absent responses to the CRH test: they were diagnosed as affected with preclinical Cushing's syndrome. An exogenous ACTH test performed in 30 patients caused a normal cortisol rise. Basal mean 17-hydroxy-progesterone (17-OHP) levels were not different from those in normal subjects.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7711879     DOI: 10.1530/eje.0.1320422

Source DB:  PubMed          Journal:  Eur J Endocrinol        ISSN: 0804-4643            Impact factor:   6.664


  21 in total

Review 1.  Endogenous subclinical hypercortisolism: Diagnostic uncertainties and clinical implications.

Authors:  S Tsagarakis; D Vassiliadi; N Thalassinos
Journal:  J Endocrinol Invest       Date:  2006-05       Impact factor: 4.256

2.  The natural history of incidentally discovered adrenocortical adenomas: a retrospective evaluation.

Authors:  E Grossrubatscher; F Vignati; M Possa; P Lohi
Journal:  J Endocrinol Invest       Date:  2001-12       Impact factor: 4.256

Review 3.  The clinical evaluation of silent adrenal masses.

Authors:  B Ambrosi; E Passini; T Re; L Barbetta
Journal:  J Endocrinol Invest       Date:  1997-02       Impact factor: 4.256

Review 4.  Subclinical Cushing's syndrome.

Authors:  Massimo Terzolo; Giuseppe Reimondo; Silvia Bovio; Alberto Angeli
Journal:  Pituitary       Date:  2004       Impact factor: 4.107

5.  Pre-Cushing's syndrome not recognized by conventional dexamethasone suppression-tests in an adrenal "incidentaloma" patient.

Authors:  M Torlontano; M Zingrillo; L D'Aloiso; M R Ghiggi; A Di Cerbo; A Scillitani; G Petracca-Ciavarella; A Liuzzi
Journal:  J Endocrinol Invest       Date:  1997-09       Impact factor: 4.256

6.  17-Hydroxyprogesterone response to ACTH in bilateral and monolateral adrenal incidentalomas.

Authors:  G P Bernini; G Brogi; M S Vivaldi; G F Argenio; M Sgrò; A Moretti; A Salvetti
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

7.  1,161 patients with adrenal incidentalomas: indications for surgery.

Authors:  A A Kasperlik-Załuska; M Otto; A Cichocki; E Rosłonowska; J Słowinska-Srzednicka; W Zgliczyński; W Jeske; L Papierska; T Tołłoczko; J Polański; R Słapa
Journal:  Langenbecks Arch Surg       Date:  2007-11-10       Impact factor: 3.445

8.  Serum bone Gla protein and carboxyterminal cross-linked telopeptide of type I collagen in patients with Cushing's syndrome.

Authors:  A Sartorio; A Conti; S Ferrario; E Passini; T Re; B Ambrosi
Journal:  Postgrad Med J       Date:  1996-07       Impact factor: 2.401

9.  The relation of adiponectin and tumor necrosis factor alpha levels between endothelial nitric oxide synthase, angiotensin-converting enzyme, transforming growth factor beta, and tumor necrosis factor alpha gene polymorphism in adrenal incidentalomas.

Authors:  E Harman; M Karadeniz; C Biray; A Zengi; S Cetinkalp; A G Ozgen; F Saygili; A Berdeli; C Gündüz; C Yilmaz
Journal:  J Endocrinol Invest       Date:  2009-05-12       Impact factor: 4.256

10.  Utility of plasma dehydroepiandrosterone sulphate determination in adrenal incidentalomas.

Authors:  G P Bernini; G F Argenio; M S Vivaldi; A Moretti; P Miccoli; P Iacconi; A Magagna; A Salvetti
Journal:  J Endocrinol Invest       Date:  1998-06       Impact factor: 4.256

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.